ABSTRACT
Insulin resistance (IR) is a major public health problem that can lead to many dangerous medical disorders and earlymortality. This study aimed to explore the effectiveness of resveratrol (RSV) to counteract the neuro-complicationsaccompanying high fat, high fructose (HFHF) diet experimentally induced-IR in rats. IR was induced by the ingestion ofHFHF diet for 70 days, 80 juvenile rats were used, and the treatments were given orally for the diet latest 10 days. Rats’general behavior was assessed by open field test (OFT) and forced swimming test (FST). On biochemical level; neurocomplications were assessed by measuring brain levels of monoamines and their metabolites as well as the levels of8-hydroxyguanosine (8-OHDG), tumor necrosis factor-α (TNF-α), malondialdehyde (MDA), reduced and oxidizedglutathione (GSH and GSSG) and nitric oxide (NOx). Oral RSV (20 and 40 mg/kg p.o) increased the activity ofthe rats in the OFT and decreased the immobility period in the FST in a dose-dependent manner. Moreover, RSVreduced monoamines turnover, elevated GSH, and reduced GSSG, NOx, MDA, 8-OHDG, and TNF-α (p < 0.05).RSV exhibited neuro-protective activities against HFHF-induced IR, thus it can be recommended as a favorable dailydietary supplement for treating the neuronal side effects related to IR.
ABSTRACT
Resveratrol (RSV) is a natural polyphenol with diverse biological activities, including potent hepato-protective and antidepressant-like effects. Fluoxetine (FLX) is one of the most commonly prescribed antidepressant drugs, however; it has recently been postulated to induce liver damage. The present study aimed to assess the benefits of combining half the conventional doses of RSV and FLX in an acute reserpine model of depression. Depression was induced in mice by a single i.p. reserpine injection. Oral administration of FLX (10 mg/kg), RSV (80 mg/kg) or their combination (FLX; 5 mg/kg and RSV; 40mg/kg) started one hour after reserpine injection and daily for the following two consecutive days. Behavioral tests were performed on the third day. Brain monoamines were assessed. Prevention of neurodegeneration and preservation potential of the DNA integrity were determined according to the brain nitric oxide and 8-hydroxy-2-deoxyguanosine contents. Effect on oxidative stress in both brain and liver was evaluated. Results revealed that combining half the dose of FLX with RSV showed antidepressant activity that was comparable to the effect of using FLX alone and in conclusion; we recommend that further investigations should be conducted to assess the applicability of using combinations of RSV and FLX to treat depression.
ABSTRACT
Abstract Securigera securidaca (L.) Degen & Döefl., Fabaceae, has been widely used in the Iranian, Indian and Egyptian folk medicine as antidiabetic and anti-hyperlipidemic remedy. Phenolic profiling of the ethanolic extract (90%) of the flowers of S. securidaca was performed via HPLC-DAD-MS/MS analysis in the positive and negative ion modes. The total polyphenols and flavonoids in the flowers were determined colorimetrically, and the quantification of their components was carried out using HPLC-UV. Total phenolics and flavonoids estimated as gallic acid and rutin equivalents were 82.39 ± 2.79 mg/g and 48.82 ± 1.95 mg/g of the dried powdered flowers, respectively. HPLC-DAD-MS/MS analysis of the extract allowed the identification of 39 flavonoids and eight phenolic acids. Quantitative analysis of some flavonoids and phenolics (mg/100 g powdered flowers) revealed the presence of isoquercetrin (3340 ± 2.1), hesperidin (32.09 ± 2.28), naringin (197.3 ± 30.16), luteolin (10.247 ± 0.594), chlorogenic acid (84.22 ± 2.08), catechin (3.94 ± 0.57) and protocatechuic acid (34.4 ± 0.15), in the extract. Moreover, the acute toxicity, hypoglycemic and hypolipidemic effects of the extract were investigated using alloxan induced diabetes in rats in a dose of 100, 200, and 400 mg/kg bwt. The ethanolic extract was safe up to a dose of 2000 mg/kg. All tested doses of the flower extract showed marked decrease in blood glucose level by 31.78%, 66.41% and 63.8% at 100, 200 and 400 mg/kg bwt, respectively, at p < 0.05. Regarding the anti-hyperlipidemic effect, a dose of 400 mg/kg of the flower extract showed the highest reduction in serum triacylglycerides and total cholesterol levels (68.46% and 51.50%, respectively at p < 0.05). The current study proved the folk use of the flowers of S. securidaca as anti-diabetic and anti-hyperlipidemic agent which could be attributed to its high phenolic content.